Skip to main content

Therapeutic Measures for Prevention of Allergic Rhinitis/Asthma Development

Buy Article:

$31.50 plus tax (Refund Policy)

The development of asthma and allergic disease involves not only genetic factors but environmental influences as well. Preventative measures may involve changes in breastfeeding, diet, environmental exposure, medications, and vaccination methods. Breastfeeding is recommended during the first 4-6 months of life. Probiotics should be consumed by mothers during pregnancy and breast-feeding. Solid foods should not be introduced to high-risk infants until four months of age. Consumption of dairy products should be delayed until 1 year, eggs until 2 years, and peanuts, nuts, and fish until 3 years of age. Exposure to tobacco smoke should be avoided by the expectant mother and by the child after birth. Ample evidence suggests that dust-mite avoidance should be performed. Diets rich in antioxidants and omega-3 fatty acids should be encouraged. No current recommended changes in vaccination practices have been proposed. Because allergy and asthma is a multifactorial process with both complex genetic and environmental components, it is unlikely that a single intervention will have a significant impact on their prevalence.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Regular Paper

Publication date: 01 January 2004

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more